.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Covington
Julphar
Chinese Patent Office
Healthtrust
AstraZeneca
Moodys
Farmers Insurance
Citi
Merck

Generated: October 15, 2018

DrugPatentWatch Database Preview

Ingredient-type: Polymyxins

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn IncTRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATEpolymyxin b sulfate; trimethoprim sulfateSOLUTION/DROPS;OPHTHALMIC065006-001Dec 17, 1998ATRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Sandoz IncTRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATEpolymyxin b sulfate; trimethoprim sulfateSOLUTION/DROPS;OPHTHALMIC064211-001Apr 13, 1998ATRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Bausch And LombTRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATEpolymyxin b sulfate; trimethoprim sulfateSOLUTION/DROPS;OPHTHALMIC064120-001Feb 14, 1997ATRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
AllerganPOLYTRIMpolymyxin b sulfate; trimethoprim sulfateSOLUTION/DROPS;OPHTHALMIC050567-001Oct 20, 1988ATRXYesYes➤ Sign Up➤ Sign Up➤ Sign Up
X Gen PharmsPOLYMYXIN B SULFATEpolymyxin b sulfateINJECTABLE;INJECTION063000-001Sep 30, 1994APRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Gland Pharma LtdPOLYMYXIN B SULFATEpolymyxin b sulfateINJECTABLE;INJECTION207322-001Apr 14, 2016APRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Xellia Pharms ApsPOLYMYXIN B SULFATEpolymyxin b sulfateINJECTABLE;INJECTION202766-001Jan 15, 2014APRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Citi
Cantor Fitzgerald
Moodys
Colorcon
AstraZeneca
Chinese Patent Office
Argus Health
US Department of Justice
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: